Literature DB >> 18817872

Mutant SOD1 from spinal cord of G93A rats is destabilized and binds to inner mitochondrial membrane.

Toni Ahtoniemi1, Merja Jaronen, Velta Keksa-Goldsteine, Gundars Goldsteins, Jari Koistinaho.   

Abstract

Mutations in Cu/Zn superoxide dismutase (SOD1) cause amyotrophic lateral sclerosis (ALS). Mechanisms of mutant SOD1 toxicity are unknown, but increased SOD1 activity can boost production of reactive oxygen species (ROS) in the mitochondrial intermembrane space (IMS). Using non-reducing SDS-PAGE we found that in G93A-SOD1 rats the mutant SOD1 was prominently destabilized only in the diseased spinal cord, where this mutant enzyme was also up regulated in the IMS with increased ability to bind the inner membrane of isolated non-transgenic mitoplasts. These mitoplasts increased ROS production when exposed to mutant SOD1 from the spinal cord at the presymptomatic stage. The levels of disulfide-reduced SOD1 peaked at the end stage of the disease, whereas protein disulfide isomerase (PDI), a chaperone capable of rearranging disulfide bonds between cysteine residues of SOD1, was increased prior to the end stage. IMS binding and increased ROS production by destabilized SOD1 may contribute to mitochondrial damage in G93A-SOD1 rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817872     DOI: 10.1016/j.nbd.2008.08.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  20 in total

Review 1.  Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis.

Authors:  Giovanni Manfredi; Hibiki Kawamata
Journal:  Neurobiol Dis       Date:  2015-08-15       Impact factor: 5.996

2.  Marked synergism between mutant SOD1 and glutamate transport inhibition in the induction of motor neuronal degeneration in spinal cord slice cultures.

Authors:  Hong Z Yin; John H Weiss
Journal:  Brain Res       Date:  2012-02-09       Impact factor: 3.252

3.  The Psi(m) depolarization that accompanies mitochondrial Ca2+ uptake is greater in mutant SOD1 than in wild-type mouse motor terminals.

Authors:  Khanh T Nguyen; Luis E García-Chacón; John N Barrett; Ellen F Barrett; Gavriel David
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

Review 4.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

5.  Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats.

Authors:  Maria Nikodemova; Alissa L Small; Stephanie M C Smith; Gordon S Mitchell; Jyoti J Watters
Journal:  Neurobiol Dis       Date:  2013-11-19       Impact factor: 5.996

Review 6.  Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?

Authors:  H Muyderman; T Chen
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 7.  Intersection between Redox Homeostasis and Autophagy: Valuable Insights into Neurodegeneration.

Authors:  Hyungsun Park; Jongyoon Kim; Chihoon Shin; Seongju Lee
Journal:  Antioxidants (Basel)       Date:  2021-04-28

8.  Mechanisms of neuroprotection by protein disulphide isomerase in amyotrophic lateral sclerosis.

Authors:  Adam K Walker; Julie D Atkin
Journal:  Neurol Res Int       Date:  2011-04-11

Review 9.  SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis.

Authors:  Francesco Tafuri; Dario Ronchi; Francesca Magri; Giacomo P Comi; Stefania Corti
Journal:  Front Cell Neurosci       Date:  2015-08-25       Impact factor: 5.505

10.  Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase.

Authors:  Zeynep A Oztug Durer; Jeffrey A Cohlberg; Phong Dinh; Shelby Padua; Krista Ehrenclou; Sean Downes; James K Tan; Yoko Nakano; Christopher J Bowman; Jessica L Hoskins; Chuhee Kwon; Andrew Z Mason; Jorge A Rodriguez; Peter A Doucette; Bryan F Shaw; Joan Selverstone Valentine
Journal:  PLoS One       Date:  2009-03-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.